Neuronetics(STIM)
2.02 -0.04 -1.9417%
| 今开：2.06 | 昨收：2.06 |
| 最高：2.0771 | 最低：1.94 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.0595077E7 |
Neuronetics的热门讨论
当期报告
Neuronetics(STIM)05-07 19:35
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-006909 Act: 34 Size: 454 KB 网页链接查看全文
持股变动声明
Neuronetics(STIM)06-06 08:25
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069573 Size: 15 KB 网页链接查看全文
股东委托书协议
Neuronetics(STIM)04-12 04:05
$Neuronetics(STIM)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-019350 Act: 34 Size: 2 MB 网页链接查看全文
当期报告
Neuronetics(STIM)05-07 19:35
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001558370-24-006907 Act: 34 Size: 149 KB 网页链接查看全文
专项披露公告
Neuronetics(STIM)05-31 04:05
$Neuronetics(STIM)$ SD Specialized disclosure report Accession Number: 0001193125-24-150322 Act: 34 Size: 246 KB 网页链接查看全文
持股变动声明
Neuronetics(STIM)06-06 08:25
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069564 Size: 15 KB 网页链接查看全文
Neuronetics的最新讨论
美股律师郝俊波2021-10-15 13:53
$Neuronetics(STIM)$
【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果，预计第三季度的总收入约为 1380 万美元，而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引，预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
TOPVIEW | 2021.8.3 Bio-market主要涨跌一览
蹊之美股生物医药2021-08-04 23:10
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
![[买]](http://js.xueqiu.com/ugc/images/face/emoji_54_buy.png?v=1 "[买]"){kind=small}
Neuronetics的公告
持股变动声明
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069983 Size: 4 KB 网页链接
当期报告
$Neuronetics(STIM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-155511 Act: 34 Size: 6 MB 网页链接
持股变动声明
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069564 Size: 15 KB 网页链接
持股变动声明
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069573 Size: 15 KB 网页链接
持股变动声明
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069576 Size: 15 KB 网页链接
持股变动声明
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069567 Size: 14 KB 网页链接
当期报告
$Neuronetics(STIM)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-153005 Act: 34 Size: 150 KB 网页链接
专项披露公告
$Neuronetics(STIM)$ SD Specialized disclosure report Accession Number: 0001193125-24-150322 Act: 34 Size: 246 KB 网页链接
季度财报
$Neuronetics(STIM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007073 Act: 34 Size: 7 MB 网页链接
当期报告
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-006909 Act: 34 Size: 454 KB 网页链接